NEWS - Porosome Therapeutics, Inc.

Pororosome Therapeutics, Inc., Launches "PorosomeAI.com" with over 10 Drug Candidates in its Pipeline & Thousands Awaiting Discovery.

Porosome Therapeutics Leadership Meets with the Principal Scientific Adviser to the Government of India

Porosome Therapeutics India Pvt. Ltd. Launched

Porosome Therapeutics Holds Global Medicine & Food Security Symposium

Government of India Announces Partnership with Porosome Therapeutics, Inc.

Porosome Therapeutics Chairman Prof. Dr. Bhanu P. Jena and CEO Guillermo Marmol attended (by invitation only) “Translation 2026” at MIT.

Mechanism of action of Porosome Therapeutics Lead Alzheimer's Drug Explained in a 1 min Video - Copy

Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)

From the Chairman's Desk (Feb. 23, 2026) Porosome Therapeutics Therapies

From the CEO's DESK (2026)

Porosome Therapeutics Chairman Prof. Dr. Bhanu P. Jena, and Chairman of the Scientific Advisory Board Prof. Dr. Joachim Frank meet with leaders of India’s Science and Technology program and present National Lectures.

From the CEO's DESK (2025)

1
2
3
4
»